ReviewCancer pathogenesis and therapy2025

Epithelial-mesenchymal transition (EMT) and its role in acquired epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) chemoresistance in non-small cell lung cancer (NSCLC).

Ma Carmela P Dela Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.